AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
ROLE OF INTERFERON-ALPHA-2B IN THE INDUCTION AND MAINTENANCE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA - RESULTS FROM A PROSPECTIVE, MULTICENTER TRIAL WITH DOUBLE RANDOMIZATION
Authors: ARRANZ R GARCIAALFONSO P SOBRINO P ZAMORA P CARRION R GARCIALARANA J PEREZ G LOPEZ J LAVILLA E LOZANO M RAYON C COLOMER R BARON MG FLORES E PEREZMANGA G FERNANDEZRANADA JM
Citation: R. Arranz et al., ROLE OF INTERFERON-ALPHA-2B IN THE INDUCTION AND MAINTENANCE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA - RESULTS FROM A PROSPECTIVE, MULTICENTER TRIAL WITH DOUBLE RANDOMIZATION, Journal of clinical oncology, 16(4), 1998, pp. 1538-1546
PERSISTENT POLYCLONAL B-LYMPHOCYTOSIS WITH MULTIPLE BCL-2 IGH REARRANGEMENTS - A BENIGN DISORDER/
Authors: GRANADOS E LLAMAS P PINILLA I TOMAS JF FONT P CAMARA R OLMEDA F ARRANZ R FERNANDEZRANADA JM
Citation: E. Granados et al., PERSISTENT POLYCLONAL B-LYMPHOCYTOSIS WITH MULTIPLE BCL-2 IGH REARRANGEMENTS - A BENIGN DISORDER/, Haematologica, 83(4), 1998, pp. 369-375
UNEXPECTED LATE GRAFT FAILURE 9 MONTHS AFTER HLA-IDENTICAL BONE-MARROW TRANSPLANT (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) - TREATMENT WITHA 2ND BMT
Authors: GILFERNANDEZ JJ ARRANZ R CAMARA R ALEGRE A FIGUERA A FERNANDEZRANADA JM
Citation: Jj. Gilfernandez et al., UNEXPECTED LATE GRAFT FAILURE 9 MONTHS AFTER HLA-IDENTICAL BONE-MARROW TRANSPLANT (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) - TREATMENT WITHA 2ND BMT, Haematologica, 83(3), 1998, pp. 285-287
AUTOIMMUNE LIVER-DISEASE (AILD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: GARCIABUEY L MATEOS FG PINILLA I BLAS C ARRANZ R GARCIASANCHEZ A MORENOOTERO R
Citation: L. Garciabuey et al., AUTOIMMUNE LIVER-DISEASE (AILD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Hepatology, 28(4), 1998, pp. 1957-1957
ABSENCE OF INFLUENCE OF PRIOR TREATMENT WITH INTERFERON ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA
Authors: TOMAS JF LOPEZLORENZO JL REQUENA MJ AGUILAR R STEEGMANN JL CAMARA R ALEGRE A ARRANZ R FIGUERA A FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ABSENCE OF INFLUENCE OF PRIOR TREATMENT WITH INTERFERON ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 22(1), 1998, pp. 47-51
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR POOR PROGNOSTIC HODGKINS-DISEASE (HD) - COMPARATIVE RESULTS WITH 2 CBV REGIMENS AND IMPORTANCE OF DISEASE STATUS AT TRANSPLANT
Authors: ARRANZ R TOMAS JF GILFERNANDEZ JJ MARTINEZCHAMORRO C GRANADOS E ALEGRE A FIGUERA A VAZQUEZ L CAMARA R FERNANDEZRANADA JM
Citation: R. Arranz et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR POOR PROGNOSTIC HODGKINS-DISEASE (HD) - COMPARATIVE RESULTS WITH 2 CBV REGIMENS AND IMPORTANCE OF DISEASE STATUS AT TRANSPLANT, Bone marrow transplantation, 21(8), 1998, pp. 779-786
BONE-MARROW TRANSPLANTATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - COMPARISON OF BUSULFAN VS TOTAL-BODY IRRADIATION (TBI) AS CONDITIONING
Authors: CAMARA R GRANADOS E GIL JJ AGUILAR R TOMAS JF FIGUERA A ARRANZ R FERNANDEZRANADA JM
Citation: R. Camara et al., BONE-MARROW TRANSPLANTATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - COMPARISON OF BUSULFAN VS TOTAL-BODY IRRADIATION (TBI) AS CONDITIONING, Bone marrow transplantation, 21, 1998, pp. 359-359
CLINICAL-EXPERIENCE IN THE TREATMENT OF CHRONIC HEPATITIS-C VIRUS-INFECTION AFTER ALLOGENEIC BMT WITH INTERFERON ALONE OR IN COMBINATION WITH PHLEBOTOMIES
Authors: TOMAS JF GOMEZGARCIA V PINILLA I ARRANZ R CAMARA R FIGUERA A FERNANDEZRANADA JM
Citation: Jf. Tomas et al., CLINICAL-EXPERIENCE IN THE TREATMENT OF CHRONIC HEPATITIS-C VIRUS-INFECTION AFTER ALLOGENEIC BMT WITH INTERFERON ALONE OR IN COMBINATION WITH PHLEBOTOMIES, Bone marrow transplantation, 21, 1998, pp. 520-520
PBSC HARVESTING FOR AUTOLOGOUS TRANSPLANT - SIMPLIFICATION OF THE PROCEDURE AFTER 8 YEARS OF EXPERIENCE IN A SINGLE-CENTER
Authors: ALEGRE A MARTINEZCHAMORRO C AGUILAR R GILFERNANDEZ JJ GRANDA A PAJUELO FJ FERNANDEZVILLALTA MJ TOMAS JF ARRANZ R FIGUERA A CAMARA R FERNANDEZRANADA JM
Citation: A. Alegre et al., PBSC HARVESTING FOR AUTOLOGOUS TRANSPLANT - SIMPLIFICATION OF THE PROCEDURE AFTER 8 YEARS OF EXPERIENCE IN A SINGLE-CENTER, Bone marrow transplantation, 21, 1998, pp. 679-679
COMPARISON OF PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH MULTIPLE-MYELOMA - HIGH-DOSE CYCLOPHOSPHAMIDE PLUS GM-CSF VS G-CSF ALONE
Authors: ALEGRE A TOMAS JF MARTINEZCHAMORRO C GILFERNANDEZ JJ FERNANDEZVILLALTA MJ ARRANZ R DIAZ MA GRANDA A BERNARDO MR ESCUDERO A LOPEZLORENZO JL FERNANDEZRANADA JM
Citation: A. Alegre et al., COMPARISON OF PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH MULTIPLE-MYELOMA - HIGH-DOSE CYCLOPHOSPHAMIDE PLUS GM-CSF VS G-CSF ALONE, Bone marrow transplantation, 20(3), 1997, pp. 211-217
REDUCTION OF BONE MASS IN WOMEN AFTER BONE-MARROW TRANSPLANTATION
Authors: CASTANEDA S CARMONA L CARVAJAL I ARRANZ R DIAZ A GARCIAVADILLO A
Citation: S. Castaneda et al., REDUCTION OF BONE MASS IN WOMEN AFTER BONE-MARROW TRANSPLANTATION, Calcified tissue international, 60(4), 1997, pp. 343-347
EXTENSIVE BONE-MARROW NECROSIS PRECEDING LARGE-CELL LYMPHOMA
Authors: ARRANZ R GILFERNANDEZ JJ ACEVEDO A FERNANDEZRANADA JM
Citation: R. Arranz et al., EXTENSIVE BONE-MARROW NECROSIS PRECEDING LARGE-CELL LYMPHOMA, Medicina Clinica, 109(10), 1997, pp. 398-399
AUTOLOGOUS BONE-MARROW TRANSPLANT IN ACUT E MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - CLINICAL-RESULTS IN 41 PATIENTS
Authors: TOMAS JF DESORIA VGG PINILLA I LAMANA M FIGUERA A ARRANZ R CAMARA R FERNANDEZVILLALTA MJ ALEGRE A FERNANDEZRANADA JM
Citation: Jf. Tomas et al., AUTOLOGOUS BONE-MARROW TRANSPLANT IN ACUT E MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - CLINICAL-RESULTS IN 41 PATIENTS, Medicina Clinica, 108(6), 1997, pp. 201-206
PROGNOSIS FACTORS IN LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF AN ANALYSIS PERFORMED IN 124 PATIENTS HOMOGENEOUSLY TREATED
Authors: ARRANZ R LLAMAS P BLAS C COLOMER R SOBRINO P NICOLAS C ALFONSO PG ZAMORA P LOPEZ J PEREZ G GARCIALARANA J LOZANO M FERNANDEZRANADA JM
Citation: R. Arranz et al., PROGNOSIS FACTORS IN LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF AN ANALYSIS PERFORMED IN 124 PATIENTS HOMOGENEOUSLY TREATED, Blood, 90(10), 1997, pp. 3868-3868
IMPORTANCE OF IRON OVERLOAD AND EFFECTIVENESS OF PHLEBOTOMY IN LONG-TERM LIVER DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN NON-THALASSEMIC PATIENTS
Authors: TOMAS JF DESORIA VGG PINILLA I PAJUELO F GRANADOS E ARRANZ R CAMARA R FIGUERA A ALEGRE A FERNANDEZRANADA JM
Citation: Jf. Tomas et al., IMPORTANCE OF IRON OVERLOAD AND EFFECTIVENESS OF PHLEBOTOMY IN LONG-TERM LIVER DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN NON-THALASSEMIC PATIENTS, Blood, 90(10), 1997, pp. 4478-4478
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PRIMARY REFRACTORY HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 44 PATIENTS FROM THE SPANISH GEL TAMO COOPERATIVE GROUP/
Authors: SUREDA A GARCIACONDE J SIERRA J TOMAS JF JARQUE I CONDE E CABALLERO D LEONLARA A MALDONADO J CALLIS M CARRERA D LOPEZ A MATAIX R MORALEDA JM PEREZLOPEZ A ARRANZ R BRUNET S MONTSERRAT E SOLANO C SANZ MA DOMINGOALBOS A
Citation: A. Sureda et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PRIMARY REFRACTORY HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 44 PATIENTS FROM THE SPANISH GEL TAMO COOPERATIVE GROUP/, Blood, 90(10), 1997, pp. 4584-4584
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - THE EXPERIENCE OF THE GEL TAMO SPANISH COOPERATIVE GROUP/
Authors: CONDE E BOSCH F ARRANZ R CABALLERO D LAHUERTA JJ GARCIACONDE J FERNANDEZRANADA JM LEON A IRIONDO A BESALDUCH J GRANENA A CARRERA D MARIN J BRUNET S MALDONADO J MORALEDA JM RUBIO D MEDIAVILLA JD VIVANCOS P PIRIS MA MONTSERRAT E
Citation: E. Conde et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - THE EXPERIENCE OF THE GEL TAMO SPANISH COOPERATIVE GROUP/, Blood, 90(10), 1997, pp. 1020-1020
QUINTON-MAHURKAR CATHETER AS SHORT-TERM CENTRAL VENOUS ACCESS FOR PBSC COLLECTION - SINGLE-CENTER EXPERIENCE OF 370 APHERESES IN 110 PATIENTS
Authors: ALEGRE A REQUENA MJ FERNANDEZVILLALTA MJ ORTS M GILSANZ F TOMAS JF ARRANZ R GILFERNANDEZ JJ GRANDA A BERNARDO MR PASSANISI M GRANADOS E FERNANDEZRANADA JM
Citation: A. Alegre et al., QUINTON-MAHURKAR CATHETER AS SHORT-TERM CENTRAL VENOUS ACCESS FOR PBSC COLLECTION - SINGLE-CENTER EXPERIENCE OF 370 APHERESES IN 110 PATIENTS, Bone marrow transplantation, 18(5), 1996, pp. 865-869
CLINICAL-RESULTS OF A STRINGENT POLICY ON PROPHYLACTIC PLATELET TRANSFUSION - NONRANDOMIZED COMPARATIVE-ANALYSIS IN 190 BONE-MARROW TRANSPLANT PATIENTS FROM A SINGLE INSTITUTION
Authors: GILFERNANDEZ JJ ALEGRE A FERNANDEZVILLALTA MJ PINILLA I GARCIA VG MARTINEZ C TOMAS JF ARRANZ R FIGUERA A CAMARA R FERNANDEZRANADA JM
Citation: Jj. Gilfernandez et al., CLINICAL-RESULTS OF A STRINGENT POLICY ON PROPHYLACTIC PLATELET TRANSFUSION - NONRANDOMIZED COMPARATIVE-ANALYSIS IN 190 BONE-MARROW TRANSPLANT PATIENTS FROM A SINGLE INSTITUTION, Bone marrow transplantation, 18(5), 1996, pp. 931-935
AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOBLASTIC-LEUKEMIA IN 2ND COMPLETE REMISSION - IMPORTANCE OF DURATION OF FIRST COMPLETE REMISSION IN FINAL OUTCOME
Authors: TOMAS JF DESORIA VGG LOPEZLORENZO JL ARRANZ R FIGUERA A CAMARA R ALEGRE A FERNANDEZRANADA JM
Citation: Jf. Tomas et al., AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOBLASTIC-LEUKEMIA IN 2ND COMPLETE REMISSION - IMPORTANCE OF DURATION OF FIRST COMPLETE REMISSION IN FINAL OUTCOME, Bone marrow transplantation, 17(6), 1996, pp. 979-984
IMIPENEM COMBINED WITH TEICOPLANIN OR VAN COMYCIN IN THE INITIAL EMPIRIC THERAPY OF FEBRILE NEUTROPENIA - ANALYSIS OF THE PRIMARY RESPONSE AND OF AN OVERALL SEQUENTIAL STRATEGY IN 126 EPISODES
Authors: FIGUERA A TOMAS JF HERNANDEZ L JIMENEZ ML PENARRUBIA MJ DELREY MC ARRANZ R CAMARA R LOPEZLORENZO JL FERNANDEZRANADA JM
Citation: A. Figuera et al., IMIPENEM COMBINED WITH TEICOPLANIN OR VAN COMYCIN IN THE INITIAL EMPIRIC THERAPY OF FEBRILE NEUTROPENIA - ANALYSIS OF THE PRIMARY RESPONSE AND OF AN OVERALL SEQUENTIAL STRATEGY IN 126 EPISODES, Revista Clinica Espanola, 196(8), 1996, pp. 515-522
ABSENCE OF DIFFERENCE BETWEEN BONE-MARROW OR PERIPHERAL STEM-CELLS ASSOURCE OF HEMATOPOIETIC SUPPORT FOR HIGH-DOSE THERAPY IN BREAST-CANCER
Authors: TOMAS JF PEREZCARRION R PEREZMANGA G JALON J ARRANZ R ALEGRE A MENDIOLA C LOPEZLORENZO JL ESCUDERO A LOPEZPASCUAL J FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ABSENCE OF DIFFERENCE BETWEEN BONE-MARROW OR PERIPHERAL STEM-CELLS ASSOURCE OF HEMATOPOIETIC SUPPORT FOR HIGH-DOSE THERAPY IN BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 1135-1135
HYPERTRIGLYCERIDEMIA MAY BE SEVERE IN CML PATIENTS TREATED WITH INTERFERON-ALPHA
Authors: PENARRUBIA MJ STEEGMANN JL LAVILLA E CASADO F REQUENA MJ PICO M ARRANZ R FERNANDEZRANADA JM
Citation: Mj. Penarrubia et al., HYPERTRIGLYCERIDEMIA MAY BE SEVERE IN CML PATIENTS TREATED WITH INTERFERON-ALPHA, American journal of hematology, 49(3), 1995, pp. 240-241
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - CLINICAL-RESULTS AND RISK-FACTORS IN 70 PATIENTS
Authors: TOMAS JF PENARRUBIA MJ GARCIA JA FIGUERA A DESORIA VGG STEEGMANN JL ARRANZ R CAMARA R GABRIEL R VAZQUEZ L FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - CLINICAL-RESULTS AND RISK-FACTORS IN 70 PATIENTS, Medicina Clinica, 105(16), 1995, pp. 605-611
CORTICOID TREATMENT IN CASTLEMANS DISEASE
Authors: ARRANZ R
Citation: R. Arranz, CORTICOID TREATMENT IN CASTLEMANS DISEASE, Medicina Clinica, 105(16), 1995, pp. 639-639
Risultati: 1-25 | 26-30